Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00928993
Other study ID # IRB00005369
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 2009
Est. completion date June 2013

Study information

Verified date December 2019
Source Oregon Health and Science University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to learn how well an instrument called an Actiwatch-2 can determine whether a child is asleep or awake. The Actiwatch-2 (manufactured by Minimitter/Respironics of Bend, Oregon) is the brand name for an actigraphy monitor; that is, a motion sensor that is typically worn on the wrist and looks like a wrist watch. It measures and records the amount of movement a person makes each minute. After being worn overnight, data are transferred from the Actiwatch to a computer, and a program estimates whether a person is awake or asleep by analyzing the recorded movement data. The enrollment target is 80 participants. Although other actigraphy equipment has been used to monitor sleep in children, the Actiwatch-2 has not been validated in the pediatric population.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date June 2013
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender All
Age group 6 Months to 18 Years
Eligibility Inclusion Criteria:

- Children (ages 6 months to 18 years) who are undergoing a medically necessary sleep study [polysomnography (PSG)] in the OHSU Sleep Disorders Laboratory

- ASA classification I and II (children in good health)

Exclusion Criteria:

- ASA classification III, IV (children with a chronic or severe disease).

- Children with developmental delay.

- Children born extremely prematurely (before 32 weeks gestation), as these children and their parents may react differently to experimental procedures

- Children who do not speak English or whose parents do not speak English.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Multnomah Pavilion, OHSU Portland Oregon

Sponsors (2)

Lead Sponsor Collaborator
Oregon Health and Science University Philips Respironics

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT03586310 - Evaluation of the Ear-EEG System for Sleep Monitoring in Healthy Subjects N/A